FREQUENCY AND SIGNIFICANCE OF RIGHT-VENTRICULAR DYSFUNCTION DURING INFERIOR WALL LEFT-VENTRICULAR MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC THERAPY (RESULTS FROM THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION [TIMI]-II TRIAL)
被引:74
作者:
BERGER, PB
论文数: 0引用数: 0
h-index: 0
机构:BOSTON UNIV HOSP, EVANS MEM DEPT CLIN RES, BOSTON, MA 02218 USA
BERGER, PB
RUOCCO, NA
论文数: 0引用数: 0
h-index: 0
机构:BOSTON UNIV HOSP, EVANS MEM DEPT CLIN RES, BOSTON, MA 02218 USA
RUOCCO, NA
RYAN, TJ
论文数: 0引用数: 0
h-index: 0
机构:BOSTON UNIV HOSP, EVANS MEM DEPT CLIN RES, BOSTON, MA 02218 USA
RYAN, TJ
JACOBS, AK
论文数: 0引用数: 0
h-index: 0
机构:BOSTON UNIV HOSP, EVANS MEM DEPT CLIN RES, BOSTON, MA 02218 USA
JACOBS, AK
ZARET, BL
论文数: 0引用数: 0
h-index: 0
机构:BOSTON UNIV HOSP, EVANS MEM DEPT CLIN RES, BOSTON, MA 02218 USA
ZARET, BL
WACKERS, FJ
论文数: 0引用数: 0
h-index: 0
机构:BOSTON UNIV HOSP, EVANS MEM DEPT CLIN RES, BOSTON, MA 02218 USA
WACKERS, FJ
FREDERICK, MM
论文数: 0引用数: 0
h-index: 0
机构:BOSTON UNIV HOSP, EVANS MEM DEPT CLIN RES, BOSTON, MA 02218 USA
FREDERICK, MM
FAXON, DP
论文数: 0引用数: 0
h-index: 0
机构:BOSTON UNIV HOSP, EVANS MEM DEPT CLIN RES, BOSTON, MA 02218 USA
FAXON, DP
机构:
[1] BOSTON UNIV HOSP, EVANS MEM DEPT CLIN RES, BOSTON, MA 02218 USA
[2] MARYLAND MED RES INST, BALTIMORE, MD USA
[3] MAYO CLIN & MAYO FDN, DIV INTERNAL MED, ROCHESTER, MN 55905 USA
[4] BOSTON UNIV HOSP, DEPT MED, BOSTON, MA 02218 USA
[5] YALE UNIV, SCH MED, DEPT CARDIOL, NEW HAVEN, CT 06510 USA
To determine the effect of thrombolytic therapy on the frequency of right ventricular (RV) dysfunction, and whether RV dysfunction is a risk factor for morbidity and mortality after discharge from the hospital, 1,110 patients in the Thrombolysis in Myocaridal Infarction (TIMI) II trial with acute inferior wall left ventricular myocardial infarction were studied. RV dysfunction was defined as an RV wall motion abnormality on equilibrium radionuclide ventriculography performed a mean of 9 days after admission the hospital. Fifty-eight patients (5%) had RV dysfunction. Baseline clinical characteristics among patients with and without RV dysfunction were similar. However, patients with RV dysfunction had a lower mean left ventricular ejection fraction (51.2 +/- 1.2% vs 55.5 +/- 0.3%; p <0.001) and a greater frequency of in-hospital complications. Angiographic data from patients undergoing protocol catheterizaiton 18 to 48 hours after hospital admission show that the infarct-related artery was more likely to be occluded in those with RV dysfunction (48% [15 of 31] vs 14% [68 of 495]; p <0.001). There was no difference in the frequency of multivessel disease between the 2 groups. In patients with RV dysfunction in whom radionuclide ventriculography was repeated 6 weeks after hospital discharge, RV wall motion abnormalities persisted in only 18% (8 of 45). Mortality in the year after discharge was 3.5% (2 of 58) among patients with RV dysfunction compared with 1.7% (18 of 1,052; p = NS) among those without RV dysfunction. Thus, RV dysfunction occurs infrequently after thrombolytic therapy, particularly in patients with patency of the infarct-related artery 18 to 24 hours after such therapy. Among surviving patients who undergo predischarge radionuclide ventriculography, RV dysfunction is not associated with a significantly increased mortality in the year after discharge from the hospital.